Market revenue in 2023 | USD 115.4 million |
Market revenue in 2030 | USD 180.7 million |
Growth rate | 6.6% (CAGR from 2023 to 2030) |
Largest segment | Consumables |
Fastest growing segment | Consumables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Consumables, Instruments |
Key market players worldwide | Thermo Fisher Scientific Inc, BD, Danaher Corp, Terumo Corp, STEMCELL Technologies, Bio-Rad Laboratories Inc, Merck KGaA, Agilent Technologies Inc, Corning Inc, Akadeum Life Sciences |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to cell separation market will help companies and investors design strategic landscapes.
Consumables was the largest segment with a revenue share of 64.99% in 2023. Horizon Databook has segmented the Sweden cell separation market based on consumables, instruments covering the revenue growth of each sub-segment from 2018 to 2030.
Sweden is expected to witness significant growth in the cell separation market due to several factors, such as the growing biopharmaceutical industry, advanced infrastructure, and supportive government initiatives in the country. Sweden has a strong R&D focus on scientific innovation and is home to leading academic institutions & research organizations.
For instance, as of December 2022, domestic biopharmaceutical companies in the country had an active innovation pipeline of 351 therapeutics. Furthermore, the country benefits from the availability of a skilled workforce in the field of biotechnology and biopharmaceuticals. Hence, a high R&D potential in the country can boost the demand for cell separation offerings and favor the market growth in Sweden.
In Sweden, the laws of MDR 2017/745 and IVD Regulation 2017/746 have been implemented. Apart from the two regulations, additional requirements are also provided by Swedish authorities. Performance studies for IVD devices are required to be approved by the Swedish Medical Products Agency or the Swedish Ethical Review Authority based on the type of authorization procedure practiced.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden cell separation market , including forecasts for subscribers. This country databook contains high-level insights into Sweden cell separation market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account